Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study.

Junier T, Rotger M, Biver E, Ledergerber B, Barceló C, Bartha I, Kovari H, Schmid P, Fux C, Bernasconi E, Brun Del Re C, Weber R, Fellay J, Tarr PE.

Open Forum Infect Dis. 2016 May 18;3(2):ofw101. doi: 10.1093/ofid/ofw101. eCollection 2016 Apr.

2.

Development of a Korean Fracture Risk Score (KFRS) for Predicting Osteoporotic Fracture Risk: Analysis of Data from the Korean National Health Insurance Service.

Kim HY, Jang EJ, Park B, Kim TY, Shin SA, Ha YC, Jang S.

PLoS One. 2016 Jul 11;11(7):e0158918. doi: 10.1371/journal.pone.0158918. eCollection 2016.

3.

Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.

Azagra R, Zwart M, Encabo G, Aguyé A, Martin-Sánchez JC, Puchol-Ruiz N, Gabriel-Escoda P, Ortiz-Alinque S, Gené E, Iglesias M, Moriña D, Diaz-Herrera MA, Utzet M, Manresa JM; GROIMAP study group.

BMC Musculoskelet Disord. 2016 Jun 17;17(1):262. doi: 10.1186/s12891-016-1096-6.

4.

Major osteoporotic fragility fractures: Risk factor updates and societal impact.

Pisani P, Renna MD, Conversano F, Casciaro E, Di Paola M, Quarta E, Muratore M, Casciaro S.

World J Orthop. 2016 Mar 18;7(3):171-81. doi: 10.5312/wjo.v7.i3.171. eCollection 2016 Mar 18. Review.

5.

The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis.

Lee JH, Sung YK, Choi CB, Cho SK, Bang SY, Choe JY, Hong SJ, Jun JB, Kim TH, Lee J, Lee HS, Yoo DH, Yoon BY, Bae SC.

BMC Musculoskelet Disord. 2016 Feb 24;17:98. doi: 10.1186/s12891-016-0952-8.

6.

Glucocorticoid-induced osteoporosis.

Briot K, Roux C.

RMD Open. 2015 Apr 8;1(1):e000014. doi: 10.1136/rmdopen-2014-000014. eCollection 2015. Review.

7.

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE.

J Bone Miner Res. 2016 Jan;31(1):16-35. doi: 10.1002/jbmr.2708. Review.

8.

Volumetric Cortical Bone Porosity Assessment with MR Imaging: Validation and Clinical Feasibility.

Rajapakse CS, Bashoor-Zadeh M, Li C, Sun W, Wright AC, Wehrli FW.

Radiology. 2015 Aug;276(2):526-35. doi: 10.1148/radiol.15141850.

PMID:
26203710
9.

3 Tesla MRI detects deterioration in proximal femur microarchitecture and strength in long-term glucocorticoid users compared with controls.

Chang G, Rajapakse CS, Regatte RR, Babb J, Saxena A, Belmont HM, Honig S.

J Magn Reson Imaging. 2015 Dec;42(6):1489-96. doi: 10.1002/jmri.24927. Epub 2015 Jun 12.

PMID:
26073878
10.

Corticosteroid use in neuro-oncology: an update.

Roth P, Happold C, Weller M.

Neurooncol Pract. 2015 Mar;2(1):6-12. Epub 2014 Oct 9.

11.

Determinants of Muscle and Bone Aging.

Curtis E, Litwic A, Cooper C, Dennison E.

J Cell Physiol. 2015 Nov;230(11):2618-25. doi: 10.1002/jcp.25001. Review.

12.

Osteoporosis in chronic obstructive pulmonary disease.

Sarkar M, Bhardwaj R, Madabhavi I, Khatana J.

Clin Med Insights Circ Respir Pulm Med. 2015 Mar 12;9:5-21. doi: 10.4137/CCRPM.S22803. eCollection 2015. Review.

13.

Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.

Overman RA, Gourlay ML, Deal CL, Farley JF, Brookhart MA, Layton JB.

Osteoporos Int. 2015 May;26(5):1515-24. doi: 10.1007/s00198-014-3022-9. Epub 2015 Jan 20.

14.

A model for time to fracture with a shock stream superimposed on progressive degradation: the Study of Osteoporotic Fractures.

He X, Whitmore GA, Loo GY, Hochberg MC, Lee ML.

Stat Med. 2015 Feb 20;34(4):652-63. doi: 10.1002/sim.6356. Epub 2014 Nov 6.

15.

Osteoporosis and risk of fracture, analysis on a population admitted in rehabilitation post-acute.

Topini C, Topini D, Cerica G, Nardocci F, Topini G.

Clin Cases Miner Bone Metab. 2014 May;11(2):129-31.

16.

Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis.

Wirth CD, Blum MR, da Costa BR, Baumgartner C, Collet TH, Medici M, Peeters RP, Aujesky D, Bauer DC, Rodondi N.

Ann Intern Med. 2014 Aug 5;161(3):189-99. doi: 10.7326/M14-0125. Review.

17.

Management issues with exogenous steroid therapy.

Patt H, Bandgar T, Lila A, Shah N.

Indian J Endocrinol Metab. 2013 Dec;17(Suppl 3):S612-7. doi: 10.4103/2230-8210.123548. Review.

18.
19.

Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer.

Saylor PJ.

Asian J Androl. 2014 May-Jun;16(3):341-7. doi: 10.4103/1008-682X.122591. Review.

20.

Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial.

Klop C, de Vries F, Vinks T, Kooij MJ, van Staa TP, Bijlsma JW, Egberts AC, Bouvy ML.

Osteoporos Int. 2014 Jan;25(1):385-92. doi: 10.1007/s00198-013-2562-8. Epub 2013 Nov 13.

Items per page

Supplemental Content

Write to the Help Desk